Sunrest Lifescience Current Share Price | Sunrest Lifescience Stock Screener
SUNREST
Pharmaceuticals
Sunrest Lifescience Current Stock Price Today
Track the current Sunrest Lifescience share price and stock price live with TickJournal's free stock screener.
Browse SUNREST annual financials to support your investment research.
Use the Sunrest Lifescience stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sunrest Lifescience Market Cap
₹66.08 Cr.
SUNREST P/E Ratio (TTM)
1.99
Sunrest Lifescience P/B Ratio
0.78
EPS (TTM)
₹7.20
Dividend Yield
-
Debt to Equity
0.41
SUNREST 52 Week High
-
Sunrest Lifescience 52 Week Low
-
Operating Margin
6.00%
Profit Margin
10.53%
SUNREST Revenue (TTM)
₹19.00
EBITDA
₹1.00
Net Income
₹2.00
Total Assets
₹41.00
Total Equity
₹19.00
Sunrest Lifescience Current Share Price Chart
Track the current Sunrest Lifescience share price and stock price with an interactive chart. Analyse SUNREST price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sunrest Lifescience stock quote in one place.
Sunrest Lifescience Company Profile - Fundamental Screener
Screen Sunrest Lifescience company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SUNREST shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0PLZ01012
Sunrest Lifescience Balance Sheet Screener
Screen SUNREST balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 41 | 35 | 25 | 17 | 13 | 10 | 6 |
| Current Assets | 33 | 28 | 25 | 16 | 13 | 9 | 6 |
| Fixed Assets | 3 | 1 | 0 | 0 | 1 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 8 | 4 | 4 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 19 | 16 | 14 | 3 | 1 | 0 | 0 |
| Share Capital | 4 | 4 | 4 | 3 | 0 | 0 | 0 |
| Reserves & Surplus | 15 | 12 | 10 | 0 | 1 | 0 | 0 |
Sunrest Lifescience Income Statement Screener - Profit & Revenue Analysis
Screen Sunrest Lifescience income statement and profit fundamentals.
Analyze SUNREST quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sunrest Lifescience share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 33 | 33 | 30 | 25 | 27 | 17 | 11 |
| Expenses | 18 | 28 | 30 | 29 | 22 | 26 | 17 | 11 |
| EBITDA | 1 | 5 | 3 | 1 | 3 | 1 | 0 | 0 |
| Operating Profit % | 6.00% | 14.00% | 9.00% | 3.00% | 12.00% | 4.00% | 2.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 4 | 3 | 1 | 3 | 1 | 0 | 0 |
| Tax | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | 2 | 3 | 2 | 0 | 2 | 1 | 0 | 0 |
| EPS | 6.60 | 7.20 | 4.66 | 0.68 | 6.81 | 2.59 | 1.66 | 0.37 |
Sunrest Lifescience Cash Flow Screener - Liquidity Fundamentals
Screen SUNREST cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 1 | -15 | 1 | 0 | 0 | -1 |
| Investing Activities | -1 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 15 | -1 | 1 | 0 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
Sunrest Lifescience Shareholding Pattern Screener
See Sunrest Lifescience shareholding pattern with promoter, FII, and DII holdings.
Check Sunrest Lifescience promoter holding and ownership changes for SUNREST on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.50% | 53.50% | 53.50% | 53.50% | 69.91% | 69.91% | 69.91% | 69.91% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.02% | 36.35% | 34.90% | 36.02% | 24.27% | 24.94% | 24.83% | 24.87% |
| Other Holding | 10.48% | 10.14% | 11.60% | 10.48% | 5.82% | 5.15% | 5.26% | 5.22% |
| Shareholder Count | 484 | 492 | 491 | 498 | 455 | 459 | 487 | 505 |
Sunrest Lifescience Share Dividend Screener - Share Yield Analysis
Check Sunrest Lifescience dividend history with payout and yield data.
View Sunrest Lifescience dividend details including ex-dates and amounts for SUNREST stock.
Sunrest Lifescience Stock Index Membership
See which indices include Sunrest Lifescience stock.
Check SUNREST index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sunrest Lifescience Market Events Screener - Corporate Actions
Get Sunrest Lifescience corporate actions including splits, bonuses, and buybacks.
Check Sunrest Lifescience stock events that may affect SUNREST share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -2.78% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 1.51% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -7.88% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 1.51% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -1.55% |
Sunrest Lifescience Competitors Screener - Peer Comparison
Screen SUNREST competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 445,652 | 36.34 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 242,904 | 83.41 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 183,699 | 85.57 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,837 | 23.87 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 102,665 | 95.29 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,344 | 30.15 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,127 | 25.82 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 93,285 | 16.93 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 92,895 | 45.72 | 14,636 | 14.85% | 1,938 | 37.66 |
Sunrest Lifescience Company Announcements - News Screener
Screen SUNREST latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.